The industry standard for DBS Services.

SpecialtyCare DBS Services & Support

Surgeons all over the country choose SpecialtyCare for our DBS services and commitment to patients. SpecialtyCare’s focused approach to DBS is unique in the industry, and the training and experience of our DBS team is unparalleled. If your hospital is considering deep brain stimulation services, or another type of surgical support, please contact us.

Services Provided by Our DBS Team

Each member of our highly trained DBS team brings a wealth of experience to every DBS lead implant case, providing unmatched support throughout every aspect of the procedure. Our staff provides a highly-customized, data-driven, and efficient mapping protocol that improves treatment efficacy without adding significant time to the surgical procedure. Contact us to learn how we can provide any combination of the following services to your hospital:

  • Provide specialized capital equipment necessary for subcortical brain mapping, including microelectrode recording and microdrive systems
  • Assistance with surgical planning
  • Set up, operation, and troubleshooting of neurophysiology systems
  • Consultation on technical issues related to the DBS procedure
  • Didactic support for OR staff, residents, and visitors regarding the theory and practice of DBS
  • Operation of microdrives that advance microelectrodes, eliminating the need for the surgeon to scrub out during the lead implant procedure
  • Identification and classification of neurons responsive to kinesthetic, tactile, or visual stimulation during MER
  • Assistance in the identification of stimulation-induced treatment efficacy and side effects
  • Summarize technical interpretation of MER and test stimulation results to the surgeon to assist in determining the optimal location for the implanted DBS lead
  • Provide scientific support for ongoing research projects


Joint Commissioned Accredited


Deep Brain Stimulation (DBS) Research

All of our DBS staff have strong research backgrounds in neuroscience, and many of them hold academic positions at prestigious institutions such as Vanderbilt University, Northwestern Medicine, and Pennsylvania State University. These appointments have allowed our staff to apply their academic training to help advance the clinical practice of DBS, as evidenced in the following publications:

Bhusal B, Stockmann J, Guerin B, Mareyam A, Kirsch J, Wald LL, Nolt MJ, Rosenow J, Lopez-Rosado R, Elahi B, Golestanirad L.  Safety and image quality at 7T MRI for deep brain stimulation systems: Ex vivo study with lead-only and full-systems.  PLoS One. 2021 Sep 7;16(9):e0257077..

Nolt MJ, Polasani RS, Masnyk TW, Rezak M, Rosenow JM. Prospective Evaluation of the Time Course of White Matter Edema Associated with Implanted Deep Brain Stimulation Electrodes. Stereotact Funct Neurosurg. 2021;99(3):203-206.

Jones MR, Baskaran AB, Nolt MJ, Rosenow JM. Intraoperative Computed Tomography for Registration of Stereotactic Frame in Frame-Based Deep Brain Stimulation. Oper Neurosurg (Hagerstown). 2021 Feb 16;20(3):E186-E189.

Huntoon KM, Young NA, Look AC, Deogaonkar M. Direct Comparison of Posterior Subthalamic Area Stimulation versus Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease. Neurol India. 2020 Jan-Feb;68(1):165-167

Young NA, Brown MP, Peng J, Kline D, Reider C, Deogaonkar M. Predicting extended hospital stay after deep brain stimulation surgery in Parkinson’s patients. J Clin Neurosci. 2019 Nov;69:241-244.

Brandmeir NJ, Brandmeir CL, Carr D, Kuzma K, McInerney J. Deep Brain Stimulation for Parkinson Disease Does not Worsen or Improve Postural Instability: A Prospective Cohort Trial. Neurosurgery. 2018 Dec 1;83(6):1173-1182.

Felix RA, Gourévitch B, Portfors CV. Subcortical pathways: Towards a better understanding of auditory disorders. Hear Res. 2018 May;362:48-60.

Park YS, Sammartino F, Young NA, Corrigan J, Krishna V, Rezai AR.Anatomic Review of the Ventral Capsule/Ventral Striatum and the Nucleus Accumbens to Guide Target Selection for Deep Brain Stimulation for Obsessive-Compulsive Disorder. World Neurosurgery. 2019 126: 1-10.

Camalier CR, Konrad PE, Gill CE, Kao C, Remple M, Nasr HM, Davis TL, Hedera P, Phibbs FT, Molinari AL, Neimat JS, Charles D. Methods for Surgical Targeting of the STN in Early-Stage Parkinson’s Disease. Front Neurol. 2014 Mar 19;5:25

Charles D, Konrad PE, Neimat JS, Molinari AL, Tramontana MG, Finder SG, Gill CE, Bliton MJ, Kao C, Phibbs FT, Hedera P, Salomon RM, Cannard KR, Wang L, Song Y, Davis TL. Subthalamic nucleus deep brain stimulation in early stage Parkinson’s disease. Parkinsonism Relat Disord. 2014 Jul;20(7):731-7.

Kahn E, D’Haese PF, Dawant B, Allen L, Kao C, Charles PD, Konrad P. Deep brain stimulation in early stage Parkinson’s disease: operative experience from a prospective randomised clinical trial. J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):164-70.

Remple MS, Bradenham CH, Kao CC, Charles PD, Neimat JS, Konrad PE. Subthalamic nucleus neuronal firing rate increases with Parkinson’s disease progression. Mov Disord. 2011 Aug 1;26(9):1657-62.

Konrad PE, Neimat JS, Yu H, Kao CC, Remple MS, D’Haese PF, Dawant BM. Customized, miniature rapid-prototype stereotactic frames for use in deep brain stimulator surgery: initial clinical methodology and experience from 263 patients from 2002 to 2008. Stereotact Funct Neurosurg. 2011;89(1):34-41.

Gilmour TP, Lieu CA, Nolt MJ, Piallat B, Deogaonkar M, Subramanian T.  The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys. Exp Neurol. 2011 Mar;228(1):53-8.

Remple MS, Sarpong Y, Neimat JS. Frontiers in the surgical treatment of Parkinson’s disease. Expert Rev Neurother. 2008 Jun;8(6):897-906.